💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Brainstorm Cell Therapeutics Inc. (BCLI)
« Back to company indexBCLI Chatter Timeline
Stock Ticker for BCLI
Most Active Tweeters for BCLI
| User | Tweets |
|---|---|
| @fierro7676 | 19 |
| @BiggerestMike | 10 |
| @MC_OptionTrades | 8 |
| @jkatcher74 | 7 |
| @Gambiste1 | 5 |
Recent Tweets for BCLI
 |
@IonisDisrupts @fierro7676 @VadersDeLorean That because $bcli charges the desperate patients in the trial 15 to 20k. Never heard of such a thing. July 3rd 2020, 9:07am |
 |
@BiggerestMike @fierro7676 @IonisDisrupts I've been following small cap biotechs for about 8 years, including $BCLI, and raising c… https://t.co/F4VABZuYQW July 3rd 2020, 8:07am |
 |
@barbaragrnbrk RT @IonisDisrupts: $bcli Expect a pr on a raise any day now. Or minute. The bankers are moving stock higher. #biotech July 2nd 2020, 7:07pm |
 |
@MarketChmln $BCLI stock gains 8.8%. View latest news. https://t.co/7SCZOSeLuN July 2nd 2020, 3:07pm |
|
@IonisDisrupts $bcli Expect a pr on a raise any day now. Or minute. The bankers are moving stock higher. #biotech July 2nd 2020, 3:07pm |
 |
@MaisaCorp $BCLI has dosed the final patient in its phase 3 trial of its product candidate NurOwn, which is intended to treat… https://t.co/7qeHGp0odS July 2nd 2020, 2:07pm |
 |
@mwscott004 RT @DavidBautz: All dosing complete in $BCLI P3 ALS trial; data in 4Q20: https://t.co/acxo2jLe9L July 2nd 2020, 1:07pm |
 |
@NewsQuantified $BCLI Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS, stock surges +8.95% https://t.co/CLpzG58bsW July 2nd 2020, 1:07pm |
 |
@BullLogic RT @StockNewsNow: $BCLI BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS https://t.co/TUGn5fUd3T July 2nd 2020, 1:07pm |
 |
@StockNewsNow $BCLI BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS https://t.co/TUGn5fUd3T July 2nd 2020, 1:07pm |
 |
@Smalcap BrainStorm Cell Therapeutics Inc. $BCLI, a leading developer of #adultstemcelltherapies for neurodegenerative disea… https://t.co/xyR4YxNhV6 July 2nd 2020, 11:07am |
 |
@PennyStocksIP BrainStorm Cell Therapeutics Inc. $BCLI, a leading developer of #adultstemcelltherapies for neurodegenerative dise… https://t.co/q1dPUGKDPM July 2nd 2020, 11:07am |
 |
@CarsonWeigel $BCLI ? maybe July 2nd 2020, 11:07am |
 |
@PennyStockPlay1 BrainStorm Cell Therapeutics Inc. $BCLI final participant dosing has been administered in the Phase 3 pivotal tria… https://t.co/Gof5ApgtXV July 2nd 2020, 11:07am |
 |
@OTCPRGROUP BrainStorm Cell Therapeutics Inc. $BCLI final participant dosing has been administered in the Phase 3 pivotal tria… https://t.co/H7AFpoLhoN July 2nd 2020, 10:07am |
 |
@DavidBautz All dosing complete in $BCLI P3 ALS trial; data in 4Q20: https://t.co/acxo2jLe9L July 2nd 2020, 8:07am |
 |
@GantosJ Important milestone for $BCLI BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in… https://t.co/OFsfBH0Cre July 2nd 2020, 7:07am |
|
@BiggerestMike RT @BioStocks: $BCLI Announces Completion of All Dosing in NurOwn Phase 3 Clinical Trial in ALS. Topline data in Q4 July 2nd 2020, 7:07am |
|
@BiggerestMike RT @JacksonJennings: $BCLI - BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS https://t.co/arNqnN5Rg3… July 2nd 2020, 7:07am |
 |
@otcdynamics $BCLI BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS https://t.co/LXjpE4oeVt July 2nd 2020, 7:07am |
 |
@JacksonJennings $BCLI - BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS https://t.co/arNqnN5Rg3 via @YahooFinance July 2nd 2020, 7:07am |
 |
@picks_horse $BCLI Announces Completion of All Dosing in NurOwn Phase 3 Clinical Trial in ALS. July 2nd 2020, 7:07am |
 |
@BioStocks $BCLI Announces Completion of All Dosing in NurOwn Phase 3 Clinical Trial in ALS. Topline data in Q4 July 2nd 2020, 7:07am |
 |
@Goose_Trading $BCLI BrainStorm Cell Therapeutics Reports Completion Of All Dosing In NurOwn Phase 3 Trial In Amyotrohpic Lateral Sclerosis July 2nd 2020, 6:07am |
 |
@sbwcws BrainStorm completes all dosing in Phase 3 pivotal trial of NurOwn in ALS $BCLI July 2nd 2020, 6:07am |
 |
@bthefirsttoknow $BCLI BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS https://t.co/oxdBjgKPDn July 2nd 2020, 6:07am |
 |
@fierro7676 RT @BiggerestMike: Interesting publication related to eye diseases and exosomes. If $BCLI considers targeting something like AMD, that wo… July 2nd 2020, 3:07am |
 |
@MC_OptionTrades $BCLI Options Synthetic Long Market in 20-Nov-20 10 Strike is Priced at a -2.5% Discount to Spot(10.90 vs 11.19) https://t.co/lpi5EBHAsl July 2nd 2020, 12:07am |
|
@BiggerestMike Interesting publication related to eye diseases and exosomes. If $BCLI considers targeting something like AMD, th… https://t.co/Az4nlaCGVk July 2nd 2020, 12:07am |
 |
@Gambiste1 RT @BiggerestMike: Interesting commentary in the $BCLI 10K Research and Development section. Anyone know anything about the neurodegenerat… July 2nd 2020, 12:07am |
|
@BiggerestMike Interesting commentary in the $BCLI 10K Research and Development section. Anyone know anything about the neurodege… https://t.co/fvCvpNAIob July 1st 2020, 11:07pm |
|
@sbwcws BrainStorm to hold a KOL conference call $BCLI July 1st 2020, 4:07pm |
|
@StockNewsNow $BCLI BrainStorm to Showcase Alzheimer's Disease Clinical Program in KOL Webinar https://t.co/heozpRWxaY July 1st 2020, 3:07pm |
|
@MC_OptionTrades $BCLI Options Synthetic Long Market in 21-Aug-20 10 Strike is Priced at a -2.6% Discount to Spot(10.75 vs 11.04) https://t.co/lpi5EBHAsl July 1st 2020, 10:07am |
 |
@jkatcher74 Next Wed $BCLI will have KOL with incredible backgrounds in Alzheimer's speak to what's coming. @BrainstormCell… https://t.co/9pRdMO9l8M July 1st 2020, 9:07am |
|
@bthefirsttoknow $BCLI BrainStorm to Showcase Alzheimer's Disease Clinical Program in KOL Webinar https://t.co/YFeEISR3yL July 1st 2020, 8:07am |
 |
@ConsumerFeed Brainstorm Cell Therapeutics $BCLI Shares Down 12.4% https://t.co/79eLkWrC8u July 1st 2020, 7:07am |
 |
@ThisLincolnian Brainstorm Cell Therapeutics $BCLI Shares Down 12.4% https://t.co/zzQHa7qniA July 1st 2020, 7:07am |
 |
@WatchlistN Brainstorm Cell Therapeutics $BCLI Trading Down 12.4% https://t.co/7opiZ9UhBK July 1st 2020, 7:07am |
|
@MC_OptionTrades $BCLI Option Markets Imply a Hard to Short Rate with the 18-Dec-20 10 Synthetic Long(10.40) at a Discount to Spot(1… https://t.co/RQ4tcdRi7J June 30th 2020, 11:06am |
|
@Gambiste1 RT @jkatcher74: Rough down day for $bcli, but hard to be mad given recent run. Next big event should be the July 8 conference call with KOL… June 30th 2020, 8:06am |
 |
@OlympiaReport Brainstorm Cell Therapeutics $BCLI Trading Down 12.4% https://t.co/e4A8RF8DPQ June 29th 2020, 7:06pm |
|
@jkatcher74 Rough down day for $bcli, but hard to be mad given recent run. Next big event should be the July 8 conference call… https://t.co/OJr0lwPKmE June 29th 2020, 4:06pm |
 |
@ahighelevation $500,000 Grant to Study #ALS Biomarkers $BCLI #neurology -https://t.co/YjhI7ETNA1 https://t.co/MZNnLX9ngy June 29th 2020, 2:06pm |
 |
@grw1177 What's going on with $BCLI ? June 29th 2020, 2:06pm |
 |
@techNICKaltradr $BCLI another long term investment making bank https://t.co/T5nTnzALlu June 29th 2020, 11:06am |
|
@fierro7676 $BCLI no stock available at IB. Interest rate 17%. June 29th 2020, 10:06am |
 |
@PaulieGualtie16 @stoolpresidente $BCLI it’s not too late to get in! June 29th 2020, 9:06am |
 |
@SwingTradeBot $BCLI technical alerts: New 52 Week High, Pocket Pivot, Upper Bollinger Band Walk, Parabolic Rise... https://t.co/EhdTYIZBwm June 29th 2020, 8:06am |
|
@ConsumerFeed Brainstorm Cell Therapeutics $BCLI Upgraded by BidaskClub to “Strong-Buy” https://t.co/VQZoT8y3Wr June 29th 2020, 5:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Make Better Decisions
Finding and Evaluating Generic and Branded Drug Market Entry Opportunities